ROMITI, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 1.537
EU - Europa 408
AS - Asia 249
AF - Africa 18
SA - Sud America 11
OC - Oceania 1
Totale 2.224
Nazione #
US - Stati Uniti d'America 1.518
IT - Italia 136
SG - Singapore 102
SE - Svezia 94
IN - India 68
CN - Cina 61
DE - Germania 46
FI - Finlandia 43
CA - Canada 16
UA - Ucraina 14
FR - Francia 13
TG - Togo 13
GB - Regno Unito 12
IE - Irlanda 10
AR - Argentina 9
BG - Bulgaria 9
JP - Giappone 8
BE - Belgio 6
RU - Federazione Russa 6
RO - Romania 4
HU - Ungheria 3
ID - Indonesia 3
IR - Iran 3
AL - Albania 2
AT - Austria 2
DK - Danimarca 2
MX - Messico 2
NL - Olanda 2
PL - Polonia 2
ZA - Sudafrica 2
BR - Brasile 1
CO - Colombia 1
ES - Italia 1
GL - Groenlandia 1
HK - Hong Kong 1
MA - Marocco 1
MC - Monaco 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.224
Città #
Fairfield 238
Chandler 138
Woodbridge 131
Ashburn 115
Seattle 101
Cambridge 87
Houston 85
Singapore 78
Wilmington 67
Dearborn 45
Rome 45
Princeton 38
Plano 36
Beijing 35
San Paolo di Civitate 34
Ann Arbor 33
Santa Clara 32
Lawrence 24
San Diego 21
Boston 20
New York 15
Des Moines 13
Lomé 13
Millbury 13
Ottawa 12
Andover 10
Dublin 10
Fremont 10
Helsinki 10
Norwalk 10
Federal 9
Sofia 9
Brussels 6
Redwood City 6
Bremen 5
Bühl 4
Guangzhou 4
Los Angeles 4
Budapest 3
Hefei 3
Jakarta 3
London 3
Mannheim 3
Munich 3
Paris 3
Rho 3
Tokyo 3
Chengdu 2
Edinburgh 2
Falkenstein 2
Falls Church 2
Florence 2
Fuzhou 2
Indiana 2
Jacksonville 2
Kunming 2
Leawood 2
Loreto 2
Mexico City 2
Milan 2
Moscow 2
Muizenberg 2
Nanchang 2
Nanjing 2
North York 2
Pisa 2
Redmond 2
San Mateo 2
Serra 2
Snohomish 2
Springfield 2
Tirana 2
Vienna 2
Acerra 1
Auckland 1
Binasco 1
Boardman 1
Bogotá 1
Boydton 1
Bristol 1
Central 1
Changsha 1
Chongqing 1
Clearwater 1
Cordenons 1
Dallas 1
Flushing 1
Frankfurt am Main 1
Grafing 1
Grottaferrata 1
Gunzenhausen 1
Hebei 1
Hounslow 1
Istanbul 1
Ivry-sur-seine 1
Jiaxing 1
Jinan 1
Kish 1
Lissone 1
Madrid 1
Totale 1.672
Nome #
Circulating tumor cells count predicts survival in colorectal cancer patients. 111
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? 99
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer 96
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX 89
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study 86
Current achievements and future perspectives of metronomic chemotherapy 84
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine 83
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer 79
17) Follow-up of intestinal metaplasia in the stomach: When, how and why. 75
Complete Regression of a Non-small Cell Lung Cancer Choroidal Metastasis with Intravitreal Bevacizumab 74
Tumors of ampulla of Vater: A case series and review of chemotherapy options. 73
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation. 73
Impact of tumor site on the prognosis of small bowel adenocarcinoma 72
Tackling pancreatic cancer with metronomic chemotherapy 70
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis 69
Study of histopathologic parameters to define the prognosis of stage II colon cancer 67
Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. 67
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice. 61
null 61
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial 60
PD-0001CAN WE PREDICT TIME TO TUMOR PROGRESSION IN EARLY COLORECTAL CANCER PATIENTS USING CTCS COUNT? 57
null 52
Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link? What both cardiologist and oncologist should know about novel angiogenesis inhibitors 48
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? 47
Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome 47
null 46
null 46
null 46
null 42
null 42
Phase II study evaluating the activity and toxicity of a biweekly schedale of gemcitabine and paclitaxel in antracycline-pretreated breast cancer 39
Metronomic chemotherapy for cancer treatment: A decade of clinical studies 38
Long-term survival in metastatic pancreatic cancer. A case report and review of the literature 32
Profiling the prognosis of gastric cancer patients. Is it worth to correlate the survival with the clinical/pathological and molecular features of gastric cancers? 32
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer 30
Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma. 30
Gastric mucosa alterations in first-degree relatives of gastric cancer patients 21
Evolving treatments for advanced gastric cancer: appraisal of the survival trend 18
A rare case of palatin tonsillar metastasis from small cell lung cancer 17
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis 17
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours 16
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art 10
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure 4
Totale 2.326
Categoria #
all - tutte 7.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.093


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020397 0 0 0 0 0 91 87 61 60 46 29 23
2020/2021176 14 22 11 8 16 19 7 16 28 14 13 8
2021/2022375 0 14 37 8 42 10 8 40 25 26 83 82
2022/2023488 76 111 26 57 47 59 9 35 32 4 25 7
2023/2024145 9 26 2 5 17 27 1 10 1 21 11 15
2024/2025157 6 34 20 27 39 31 0 0 0 0 0 0
Totale 2.326